Atria Wealth Solutions’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246K | Sell |
1,123
-2,898
| -72% | -$635K | 0.01% | 1260 |
|
|
2025
Q1 | $900K | Buy |
4,021
+1,258
| +46% | +$282K | 0.01% | 924 |
|
|
2024
Q4 | $905K | Sell |
2,763
-205
| -7% | -$67.2K | 0.01% | 957 |
|
|
2024
Q3 | $891K | Sell |
2,968
-318
| -10% | -$95.5K | 0.01% | 944 |
|
|
2024
Q2 | $1.08M | Sell |
3,286
-309
| -9% | -$102K | 0.01% | 857 |
|
|
2024
Q1 | $1.42M | Sell |
3,595
-88
| -2% | -$34.8K | 0.02% | 752 |
|
|
2023
Q4 | $1.3M | Sell |
3,683
-29
| -0.8% | -$10.2K | 0.02% | 755 |
|
|
2023
Q3 | $1.39M | Sell |
3,712
-163
| -4% | -$61.2K | 0.02% | 685 |
|
|
2023
Q2 | $1.48M | Sell |
3,875
-116
| -3% | -$44.4K | 0.02% | 681 |
|
|
2023
Q1 | $1.38M | Sell |
3,991
-149
| -4% | -$51.6K | 0.02% | 685 |
|
|
2022
Q4 | $974K | Sell |
4,140
-401
| -9% | -$94.4K | 0.02% | 760 |
|
|
2022
Q3 | $1.12M | Buy |
4,541
+568
| +14% | +$140K | 0.02% | 679 |
|
|
2022
Q2 | $1.2M | Sell |
3,973
-2,985
| -43% | -$902K | 0.02% | 609 |
|
|
2022
Q1 | $2.86M | Buy |
+6,958
| New | +$2.86M | 0.05% | 386 |
|